Aoxiang Pharmaceutical: The net profit attributable to the parent company in the first half of the year was 169 million yuan, a year-on-year decrease of 5.83%.

Aoxiang Pharmaceutical disclosed its semi-annual report on August 28th. The company achieved operating income of 482 million yuan in the first half of the year, a decrease of 2.14% year-on-year; net profit attributable to shareholders of the listed company was 169 million yuan, a decrease of 5.83% year-on-year; basic earnings per share were 0.2 yuan per share.